These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

900 related items for PubMed ID: 19577386

  • 1. Aromatase inhibitors in breast cancer.
    Hiscox S, Davies EL, Barrett-Lee P.
    Maturitas; 2009 Aug 20; 63(4):275-9. PubMed ID: 19577386
    [Abstract] [Full Text] [Related]

  • 2. Aromatase inhibitors in breast cancer therapy.
    Brueggemeier RW.
    Expert Rev Anticancer Ther; 2002 Apr 20; 2(2):181-91. PubMed ID: 12113240
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Aromatase inhibitors: future directions.
    Osborne CK, Schiff R.
    J Steroid Biochem Mol Biol; 2005 May 20; 95(1-5):183-7. PubMed ID: 16019204
    [Abstract] [Full Text] [Related]

  • 6. Emerging bone health issues in women with breast cancer in Hawai'i.
    Carney JF, Davis J.
    Hawaii Med J; 2007 Jun 20; 66(6):164-6. PubMed ID: 17621865
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prospects of neoadjuvant aromatase inhibitor therapy in breast cancer.
    Dixon JM.
    Expert Rev Anticancer Ther; 2008 Mar 20; 8(3):453-63. PubMed ID: 18366292
    [Abstract] [Full Text] [Related]

  • 10. Current topics and perspectives on the use of aromatase inhibitors in the treatment of breast cancer.
    Iwase H.
    Breast Cancer; 2008 Mar 20; 15(4):278-90. PubMed ID: 18810576
    [Abstract] [Full Text] [Related]

  • 11. Optimizing aromatase inhibitor integration into initial treatment strategies in postmenopausal women with hormone-receptor-positive early breast cancer.
    Chlebowski RT.
    Breast Cancer Res Treat; 2008 Dec 20; 112 Suppl 1():25-34. PubMed ID: 19101792
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Aromatase in the context of breast and endometrial cancer. A review.
    Jongen VH, Hollema H, Van Der Zee AG, Heineman MJ.
    Minerva Endocrinol; 2006 Mar 20; 31(1):47-60. PubMed ID: 16498363
    [Abstract] [Full Text] [Related]

  • 15. Adjuvant endocrine therapy for perimenopausal women with early breast cancer.
    Ortmann O, Cufer T, Dixon JM, Maass N, Marchetti P, Pagani O, Pronzato P, Semiglazov V, Spano JP, Vrdoljak E, Wildiers H.
    Breast; 2009 Feb 20; 18(1):2-7. PubMed ID: 19036588
    [Abstract] [Full Text] [Related]

  • 16. Sequential therapy with tamoxifen and aromatase inhibitors in early-stage postmenopausal breast cancer: a review of the evidence.
    Litsas G.
    Oncol Nurs Forum; 2008 Jul 20; 35(4):714-21. PubMed ID: 18591176
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Tamoxifen and aromatase inhibitors differentially affect vascular endothelial growth factor and endostatin levels in women with breast cancer.
    Holmes CE, Huang JC, Pace TR, Howard AB, Muss HB.
    Clin Cancer Res; 2008 May 15; 14(10):3070-6. PubMed ID: 18483373
    [Abstract] [Full Text] [Related]

  • 19. Aromatase inhibitors in the treatment of breast cancer.
    Brueggemeier RW, Hackett JC, Diaz-Cruz ES.
    Endocr Rev; 2005 May 15; 26(3):331-45. PubMed ID: 15814851
    [Abstract] [Full Text] [Related]

  • 20. Steroid metabolism in breast cancer.
    Foster PA.
    Minerva Endocrinol; 2008 Mar 15; 33(1):27-37. PubMed ID: 18277377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.